Approval · Notice of Compliance 4882 · 1995
LINBUSPIRONE: Notice of Compliance 4882
Issued July 26, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4882
- Date
- July 26, 1995
- Company
- Linson Pharma Co.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Anxiolytic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LINBUSPIRONE | 02176114 | — |
| LINBUSPIRONE | 02176122 | Cancelled Post Market |
Medicinal ingredients
- BUSPIRONE HCL 5 MG per TAB
- BUSPIRONE HCL 10 MG per TAB